wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39200937-33E5B666-BD54-4D12-A4CE-10ECF4AEE611
Q39200937-33E5B666-BD54-4D12-A4CE-10ECF4AEE611
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39200937-33E5B666-BD54-4D12-A4CE-10ECF4AEE611
Biosimilar biologic drugs: a new frontier in medical care.
P2860
Q39200937-33E5B666-BD54-4D12-A4CE-10ECF4AEE611
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39200937-33E5B666-BD54-4D12-A4CE-10ECF4AEE611
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5d59f84a2560d20c17481edf57435b7fdce06e31
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.